Authors


Jeffrey Hamper, PharmD, BCACP

Latest:

Lowering Cardiovascular Disease Risk for Patients With Diabetes

Although there are many ways a patient can reduce the risk for diabetes or complications from diabetes, pharmacists have intimate knowledge of a patient


Lindsey Peters, PharmD

Latest:

Veterinary Medicine in Community Pharmacy

Student pharmacists speak to veterinary pharmacists and veterinarians about commonly prescribed medications for companion animals.


Madeline Beyzarov

Latest:

Case Study: A Pharmacist-Parent Eyes the Zebra Side Effect in a Field Full of Horses

How a mother's intutition, and a pharmacy background, proved important in identifying a medication-related side effect.


Brad Lecompte, BSN, RN

Latest:

Smoking Cessation: Overcoming Nicotine Dependence

Pharmacists can learn about the available interventions for smoking cessation.



William Beach, MD

Latest:

Impact of Hyaluronic Acid Injections on Pain Management Medications Utilization

This study assessed the impact of initiating hyaluronic acid injections on pain management pharmacotherapies utilization patterns in patients with knee osteoarthritis.


Dan Leonard, MA, President, National Pharmaceutical Council

Latest:

Inconsistent Specialty Pharmaceutical Coverage Threatens Care Coordination, Continuity

For payers, employers, and health systems, spending on specialty medications and the spending trend remain common concerns.



Xuan Li, MS

Latest:

5-HT3 Receptor Antagonist Effects in Cancer Patients With Multiple Risk Factors

Palonosetron has been found to be effective in treating chemotherapy-induced nausea and vomiting, but no other studies that have compared it with the other 5-HT3 RAs are currently available.


Mary Elizabeth Ray, PharmD

Latest:

PharmD Students Cope With Transitions in the Wake of the COVID-19 Pandemic

The COVID-19 pandemic rapidly pushed traditional face-to-face instruction within schools of pharmacy into a fully remote learning environment.


Rodney S. Daniel, MD

Latest:

Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis

Methotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.


Ryan Marotta, Associate Editor

Latest:

Rising Drug Costs: What Are the Contributing Factors?

High prices can negatively affect patient access and adherence.



Marianna Fedorenko, PharmD Candidate

Latest:

Controlling Your HIV Infection

Patients taking antiretroviral therapy can maximize their therapy when pharmacists educate them about their medication regimens.


Jeff Goad, PharmD, MPH, APH

Latest:

Key Considerations for Pharmacists Administering RSV Vaccines

The panelists provide guidance on how pharmacists should advise patients on recognizing RSV symptoms that require urgent medical attention.


Press Release

Latest:

Touro Alumna Wins Award for Essay on Potential Economic Impact of New Drugs

Touro College of Pharmacy graduate Emil Joseph, PharmD, has won the 2016 Corporate Member Scholarship Award from the New York State Council of Health-System Pharmacists.


Alyssa K. Eakley, MS, CCRC

Latest:

Phytosterols for Lowering Cholesterol: Pharmacy Interventions to Improve Patient Outcomes

This Continuing Education activity is supported by an independent educational grant from Nature Made Nutritional Products.


Sumesh Kachroo, PhD

Latest:

Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial Fibrillation

This study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.


Melissa Badowski, PharmD, BCPS, AAHIVP

Latest:

Is Dolutegravir Monotherapy Effective in Treating HIV?

Although dolutegravir (DTG) is known for its high genetic barrier to resistance, its durability to maintain virologic suppression had not previously been evaluated.


Jack Mardekian, PhD

Latest:

Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial Fibrillation

This study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.


Andrew J. Roth, CURE

Latest:

J&J to Pay $72 Million for Ovarian Cancer Death Linked to Talcum Powder Use

Jury orders Johnson & Johnson to pay $72 million in damages to the family of a woman who died from ovarian cancer allegedly caused by products containing talcum powder.



Meghan Ross

Latest:

University of Maryland School of Pharmacy

The University of Maryland School of Pharmacy is the fourth-oldest pharmacy school in the country and has more than 5000 alumni living and working around the world.



Caryn Domenici Belisle, RPh

Latest:

Theratechnologies Inc's Egrifta

The FDA approved Egrifta (tesamorelin) to treat lipodystrophy in HIV-infected patients.


Fuller Currie, PharmD Candidate 2021

Latest:

Evaluating the Efficacy of Adjunctive Therapies Used to Treat COVID-19: The Role of Famotidine, Melatonin, and Thiamine

H2-receptor antagonists, melatonin, and thiamine are some of the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.


Gabriel E. Pray, PharmD Candidate

Latest:

Refrigeration in Hospital Pharmacy: A Penny Test for Your Thoughts?

The "penny in a cup" test offers general information about a freezer's temperature, but it lacks the necessary sensitivity to determine whether frozen medications are kept in the desired temperature range.


Alicia Rybovic

Latest:

Snyder Wins RESPy Award Through Selfless Contribution to Pharmacy

A commitment to volunteerism in his own community and abroad is the hallmark of this month's RESPy winner, Charles "Chase" Snyder.